首页 | 本学科首页   官方微博 | 高级检索  
检索        

异长春花硷与顺铂联合治疗晚期非小细胞肺癌32例报告
引用本文:范玉华,于丁,邓华邦,柯玉华,付小玉,胡艳萍,杨玲,肖志华,蒋晖.异长春花硷与顺铂联合治疗晚期非小细胞肺癌32例报告[J].临床肿瘤学杂志,2001,6(2):119-120.
作者姓名:范玉华  于丁  邓华邦  柯玉华  付小玉  胡艳萍  杨玲  肖志华  蒋晖
作者单位:湖北省肿瘤医院
摘    要:目的:观察异长春花硷(NVB)联合顺铂(PDD)组成NP方案治疗非小细胞肺癌的疗效。方法:NP方案联合治疗32例晚期非小细胞肺癌(NSCLC),其中男25例,女7例;Ⅲ期23例,Ⅳ期9例。用药方法为,NVB25mg/m^2,iv.d1,d8;PDD80mg/m^2,iv,d1每21天重复。结果:全组32例中CR1例,PR16例,SD12例,PD3例,总有效率为53.1%。NVB限制性毒性为白细胞下降(96.8%),其中Ⅲ、Ⅳ度为56.0%;静脉炎发生率为40.6%。结论:以NVB和PDD联合治疗NSCLC有效率较高,是一个较好的抗肺癌化疗方案。

关 键 词:异长春花硷  顺铂  非小细胞肺癌  化疗  NP方案
修稿时间:2000年8月12日

NVB and PDD combination chemotherapy in the treatment of advanced non-small cell lung cancer
Fan Yuhua,Yu Ding,Dend Huabang,et al..NVB and PDD combination chemotherapy in the treatment of advanced non-small cell lung cancer[J].Chinese Clinical Oncology,2001,6(2):119-120.
Authors:Fan Yuhua  Yu Ding  Dend Huabang  
Institution:Fan Yuhua,Yu Ding,Dend Huabang,et al. Department of Chemotherapy,Hubei Cancer Hospital,Wuhan 430079
Abstract:Objective: To evaluate the combined chemotherapy efficacy and toxicity of NVB and PDD regimen on advanced non-small call lung cancer.Methods: All the 32 patients were treated with NP regimen. NVB 25 mg/m2 iv, for Day 1 and 8; PDD 80mg/m iv, for day 1. The treatment was recycled every 21 days. Results: Complete response was achieved in 1 case, partial response in 16 cases, stable in 12 cases, progression in 3 cases. The overall response rate was 53.1% . Side reactions were mainly myelosuppression and phlebitis. Conclusion: The NP regimen is a better one for advanced NSCLC.
Keywords:NVB FDD NSCLC Chemotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号